AVTOZMA
CELLTRION INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of AVTOZMA in Canada?
Not currently. The most recent shortage report for AVTOZMA 400MG is marked resolved (last updated August 28, 2026).
Avtozma, Actemra & Tyenne (Tocilizumab) Shortage in Canada
Whether tocilizumab — Actemra and its biosimilars Avtozma and Tyenne — is in shortage in Canada right now, what anticipated and avoided shortage reports mean, and what to ask before switching brands.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02562049
Strength
400MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
TOCILIZUMAB
Tier
Unrated
Last Updated
2026-08-28
Reason for Shortage
Demand increase for the drug.
Other Products from CELLTRION INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02562030
162MG · DIN 02562057
80MG · DIN 02562022
162MG · DIN 02562065
2MG · DIN 02563045
2MG · DIN 02563037
440MG · DIN 02480794
150MG · DIN 02506211
75MG · DIN 02561018
150MG · DIN 02561026
150MG · DIN 02553813
75MG · DIN 02553805